| Anne Michelle Lobdell, MS AUDIOLOGY | |
|
5770 S 250 E, Suite # 285, Murray, UT 84107-8100 | |
| (801) 303-3912 | |
| Not Available |
| Full Name | Anne Michelle Lobdell |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 23 Years |
| Location | 5770 S 250 E, Murray, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669629721 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 322251-4101 (Utah) | Primary |
| 237600000X | Audiologist-hearing Aid Fitter | 3222514101 (Utah) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Utah Adult Services | 0941525273 | 1459 |
News Archive
A naturally produced molecule called resveratrol, found in the skin of red grapes, has been shown to lower insulin levels in mice when injected directly into the brain, even when the animals ate a high-fat diet.
Georgetown University Medical Center today announced the creation of a center that may help advance a cure for one of the deadliest forms of cancer. The Otto J. Ruesch Center for the Cure of Gastrointestinal (GI) Cancers will fund gastrointestinal cancer research, drug discovery and patient advocacy efforts at the Georgetown Lombardi Comprehensive Cancer Center.
A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.
Patients with a hemorrhagic ("bleeding") stroke are significantly less likely to receive medications and counseling to prevent recurrent strokes compared to patients with an ischemic (clot-caused) stroke, researchers reported at the American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
Albireo today announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The results will be presented during the 2010 Digestive Disease Week (DDW) annual meeting being held in New Orleans, US.
› Verified 3 days ago
| Provider Name | Department Of Communication |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1245338920 PECOS PAC ID: 5799725859 Enrollment ID: O20050509000127 |
News Archive
A naturally produced molecule called resveratrol, found in the skin of red grapes, has been shown to lower insulin levels in mice when injected directly into the brain, even when the animals ate a high-fat diet.
Georgetown University Medical Center today announced the creation of a center that may help advance a cure for one of the deadliest forms of cancer. The Otto J. Ruesch Center for the Cure of Gastrointestinal (GI) Cancers will fund gastrointestinal cancer research, drug discovery and patient advocacy efforts at the Georgetown Lombardi Comprehensive Cancer Center.
A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.
Patients with a hemorrhagic ("bleeding") stroke are significantly less likely to receive medications and counseling to prevent recurrent strokes compared to patients with an ischemic (clot-caused) stroke, researchers reported at the American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
Albireo today announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The results will be presented during the 2010 Digestive Disease Week (DDW) annual meeting being held in New Orleans, US.
› Verified 3 days ago
| Provider Name | University Of Utah Adult Services |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
A naturally produced molecule called resveratrol, found in the skin of red grapes, has been shown to lower insulin levels in mice when injected directly into the brain, even when the animals ate a high-fat diet.
Georgetown University Medical Center today announced the creation of a center that may help advance a cure for one of the deadliest forms of cancer. The Otto J. Ruesch Center for the Cure of Gastrointestinal (GI) Cancers will fund gastrointestinal cancer research, drug discovery and patient advocacy efforts at the Georgetown Lombardi Comprehensive Cancer Center.
A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.
Patients with a hemorrhagic ("bleeding") stroke are significantly less likely to receive medications and counseling to prevent recurrent strokes compared to patients with an ischemic (clot-caused) stroke, researchers reported at the American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
Albireo today announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The results will be presented during the 2010 Digestive Disease Week (DDW) annual meeting being held in New Orleans, US.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anne Michelle Lobdell, MS AUDIOLOGY 5770 S 250 E, Suite # 285, Murray, UT 84107-8100 Ph: (801) 303-3912 | Anne Michelle Lobdell, MS AUDIOLOGY 5770 S 250 E, Suite # 285, Murray, UT 84107-8100 Ph: (801) 303-3912 |
News Archive
A naturally produced molecule called resveratrol, found in the skin of red grapes, has been shown to lower insulin levels in mice when injected directly into the brain, even when the animals ate a high-fat diet.
Georgetown University Medical Center today announced the creation of a center that may help advance a cure for one of the deadliest forms of cancer. The Otto J. Ruesch Center for the Cure of Gastrointestinal (GI) Cancers will fund gastrointestinal cancer research, drug discovery and patient advocacy efforts at the Georgetown Lombardi Comprehensive Cancer Center.
A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.
Patients with a hemorrhagic ("bleeding") stroke are significantly less likely to receive medications and counseling to prevent recurrent strokes compared to patients with an ischemic (clot-caused) stroke, researchers reported at the American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
Albireo today announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The results will be presented during the 2010 Digestive Disease Week (DDW) annual meeting being held in New Orleans, US.
› Verified 3 days ago
Karyn K Hodge, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 4500 So. 777. E. Ste #110, Murray, UT 84107 Phone: 801-268-6497 | |
Aubrey Passey, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 5770 S 250 E Ste 170, Murray, UT 84107 Phone: 801-314-5200 | |
Dr. Daniel Glen Keller, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5171 Cottonwood St, South Office Building 8th Floor, Murray, UT 84107 Phone: 801-507-9800 Fax: 801-507-9801 | |
Kimberly Chesney Redford, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 164 E 5900 S Ste A107, Murray, UT 84107 Phone: 801-843-6113 Fax: 801-843-6114 | |
Stephen Merrill Jones, AU-D Audiologist Medicare: Medicare Enrolled Practice Location: 5171 Cottonwood St Ste 810, Murray, UT 84107 Phone: 801-507-9823 | |
Mr. Jared Cole Bumgardner, A.U.D Audiologist Medicare: Medicare Enrolled Practice Location: 5121 Cottonwood St, Murray, UT 84107 Phone: 801-507-7348 |